BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/03/2022

FDA Clears Way for Technetium Tc-99m Succimer Kit Approval

The FDA has determined that the MPI DMSA KIDNEY REAGENT (Technetium Tc-99m Succimer Kit), Injectable, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for the product.

Source: Federal Register — Food and Drug AdministrationOpen original release →